Former Apogee Therapeutics leaders join Paragon Labs to expand R&D and company creation platform
read at Endpoints ↗Positive
Michael Henderson, who previously led Apogee Therapeutics, is now serving as chief executive officer of Paragon Labs.
He is accompanied by five other former Apogee executives who have moved to Paragon to help broaden its research and development capabilities and its platform for launching new biotech companies.
The transition comes after Apogee was acquired by AbbVie for $10.9 billion, and it underscores Paragon's intent to scale its R&D and company‑creation engine.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Apogee execs join Paragon to scale its R&D, company creation engine”
read at Endpoints ↗92 words · retrieved 2h ago
comments(0)
5-min edit window · permanent after that